Biography

Mark Amsbaugh, MD, specializes in radiation oncology with an emphasis on tumors of the central nervous system, lung, head and neck, prostate and breast. He sees patients in the Texas Medical Center and Memorial City, and has experience in multiple radiotherapy delivery techniques including radiosurgery using the Leksell Gamma Knife®; stereotactic ablative body radiotherapy; image-guided and intensity-modulated radiotherapy; and high dose-rate brachytherapy.

Dr. Amsbaugh earned his medical degree at McGovern Medical School at UTHealth and completed residency training in radiation oncology at the James Graham Brown Cancer Center at the University of Louisville, Kentucky, where he served as chief resident and president of the University of Louisville House Staff. He completed a clinical fellowship in radiation oncology at The University of Texas MD Anderson Cancer Center in Houston.

Dr. Amsbaugh has authored numerous articles and has published in peer-reviewed journals including Head and Neck, Journal of Neuro-Oncology and Cancer. He is the author of several book chapters focusing on the treatment of brain tumors and radiosurgery. He has given invited national and international presentations on a variety of topics. In addition to numerous research awards, Dr. Amsbaugh has received multiple honors including the Emmet J. Conrad Award, The RSNA Roentgen Award and the University of Louisville House Staff of the Year Award.

For Patients

If you are interested in learning more about Dr. Amsbaugh’s clinical practice, please click below.

Mark J. Amsbaugh, MD


Education

Medical Degree
McGovern Medical School at UTHealth
Residency, Radiation Oncology
James Graham Brown Cancer Center at the University of Louisville, Kentucky
Clinical Fellowship, Radiation Oncology
The University of Texas MD Anderson Cancer Center

Areas of Interest

Clinical Interests

Tumors of the central nervous system, lung, head and neck, prostate and breast, radiosurgery using the Leksell Gamma Knife®; stereotactic ablative body radiotherapy; image-guided and intensity-modulated radiotherapy; and high dose-rate brachytherapy.